• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Immunic(IMUX.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
H.C. Wainwright Reiterates Buy Rating on Immunic with a Price Target of $8.00
11:42
Immunic released FY2025 9 Months Earnings on November 13 (EST), actual revenue USD 0, actual EPS USD -0.5861
04:00
Immunic released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1319 (forecast USD -0.19)
04:00
Oct27
Matthew Caufield Gives Buy Rating to Immunic's Vidofludimus Calcium
10:32
Sep25
Immunic Presents Clinical Data of Vimizim for Multiple Sclerosis Treatment
10:31
Aug8
Immunic released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD -0.4475
03:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -25.58 M, EPS -0.1319

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -26.82 M, EPS -0.2718

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -25.47 M, EPS -0.2825

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More